Warpnine Incorporated

WARPNINE is achieving its mission of improving outcomes for Australians with pancreatic, gastrointestinal, and rare cancers by funding and conducting patientcentered clinical trials. These trials drive the advancement of innovative treatment options, directly impacting survival rates and quality of life, and ensuring that donor contributions are effectively used to create tangible progress in cancer care.